Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
Patent
·
OSTI ID:874796
- Manorville, NY
- Cos Cob, CT
The present invention relates to the use of gamma vinyl-GABA (GVG) to treat obsessive-compulsive disorder (OCD) and OCD-related disorders, and to reduce or eliminate behaviors associated with obsessive-compulsive disorder (OCD) and OCD-related disorders.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
- DOE Contract Number:
- AC02-98CH10886
- Assignee:
- Brookhaven Science Associates, LLC (Upton, NY)
- Patent Number(s):
- US 6462084
- OSTI ID:
- 874796
- Country of Publication:
- United States
- Language:
- English
Similar Records
Treatment of addiction and addiction-related behavior
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder
Lack of association between obsessive-compulsive disorder and the dopamine D{sub 3} receptor gene: Some preliminary considerations
Patent
·
Wed Jan 01 00:00:00 EST 2003
·
OSTI ID:874796
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder
Journal Article
·
Thu Jun 01 00:00:00 EDT 1989
· Arch. Gen. Psychiatr.; (United States)
·
OSTI ID:874796
+6 more
Lack of association between obsessive-compulsive disorder and the dopamine D{sub 3} receptor gene: Some preliminary considerations
Journal Article
·
Thu Sep 15 00:00:00 EDT 1994
· American Journal of Medical Genetics
·
OSTI ID:874796